MELD score, Child-Pugh, liver fibrosis indices, and GI bleeding risk stratification.
Colonoscopy quality metric: proportion with >=1 adenoma.
IAIHG simplified criteria for autoimmune hepatitis (2008).
APRI: AST-to-platelet ratio index for liver fibrosis in hepatitis C.
De Ritis ratio (AST/ALT) for liver injury pattern.
Baron endoscopic score for ulcerative colitis (1964): single 0-3 grading of mucosal appearance at flexible sigmoidoscopy — 0 normal, 1 abnormal non-hemorrhagic, 2 moderately hemorrhagic (bleeds on touch), 3 severely hemorrhagic (spontaneous bleeding/ulceration).
Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma.
BBPS: rate colonoscopy bowel preparation quality (3 segments).
Classifies stool form and correlates with intestinal transit time to assess bowel health and identify constipation or diarrhea
Predicts cardiovascular risk in orthotopic liver transplantation. The CAR-OLT score predicts the 1-year risk for death or hospitalization related to a major CVD event (myocardial infarction, cardiac revascularization, heart failure, atrial fibrillation, cardiac arrest, pulmonary embolism, or stroke) after liver transplantation.
Quantifies disease activity in Crohn's disease patients using clinical symptoms and laboratory findings over a 7-day period
Estimates severity of cirrhosis and prognosis in patients with chronic liver disease
Predicts mortality in acute-on-chronic liver failure patients
Assesses severity of endoscopic findings in patients with eosinophilic esophagitis (EoE) using standardized scoring of five major endoscopic features: edema, rings, exudates, furrows, and strictures.
Predicts presence and size of esophageal varices prior to screening endoscopy in patients with cirrhosis. Helps identify patients who may safely defer endoscopic screening.
Diagnoses fatty liver using lab and exam findings. A simple and accurate predictor of hepatic steatosis in the general population.
Non-invasive estimate of liver scarring in HCV and HBV patients, to assess need for biopsy. Calculated as (Age × AST) / (Platelet count × √ALT)
Screens for fibrotic NASH in individuals at high risk for NAFLD. Uses AST, HbA1c, and HDL cholesterol to calculate probability of fibrotic nonalcoholic steatohepatitis.
Noninvasive fibrosis index for chronic hepatitis C.
Stratifies severity of upper GI bleeding according to endoscopic findings. Helps prognosticate and risk stratify patients, guides endoscopic therapeutic decisions, and assists in determining discharge versus inpatient monitoring.
6-item symptom questionnaire estimating likelihood of GERD; score >= 8 suggests GERD.
Prognostic score for mortality prediction in patients with alcoholic hepatitis using five clinical variables: age, white blood cell count, urea, prothrombin time ratio, and bilirubin. More accurate than the modified Discriminant Function for predicting 28-day mortality
Clinical scoring system to assess the risk of upper gastrointestinal bleeding and identify patients who may need medical intervention such as blood transfusion or endoscopic intervention. Used to stratify patients for safe outpatient management versus hospital admission.
Predicts need for hospital-based intervention or death in upper GI bleeding. A score of 0 identifies very-low-risk patients who may be managed as outpatients.
Clinical scoring system to assess the severity of acute pancreatitis using 8 laboratory and clinical parameters. Helps predict mortality risk and guide management decisions including ICU admission and treatment intensity. Uses the PANCREAS mnemonic for easy recall.
Identifies patients who do not require intensive care for their first episode of acute pancreatitis. The HAPS enables identification, within approximately 30 minutes after admission, of patients with acute pancreatitis whose disease will run a mild course.
Stratifies severity of Crohn's disease using only clinical parameters. A simplified version of the Crohn's Disease Activity Index (CDAI) that correlates 93% with CDAI but doesn't require laboratory tests.
Defines criteria for the stages of hepatic encephalopathy based on West Haven Criteria. This semi-quantitative grading system assesses mental state based on changes in consciousness, intellectual function, behavior, and neuromuscular abnormalities.
Stages complicated diverticulitis severity to guide medical vs surgical management.
Mayo HISORt criteria for diagnosing autoimmune pancreatitis from histology, imaging, serology, other-organ involvement and steroid response.
Predicts outcome of medical therapy in severe ulcerative colitis by assessing risk of failure of corticosteroid therapy on day 3 of admission.
Classifies severity of eosinophilic esophagitis (EoE) using a comprehensive scoring system that evaluates symptoms, complications, inflammatory features, and fibrostenotic changes. The I-SEE was developed by a multidisciplinary international group of EoE experts to standardize disease severity assessment beyond eosinophil counts alone. This validated clinical tool helps guide practitioners in EoE management by providing standardized disease severity classification that correlates with clinical features, treatment response, and need for interventions such as dilation. The score evaluates multiple domains including symptom frequency, complications (food impaction, hospitalization), inflammatory features (edema, furrows, exudates, eosinophil counts), and fibrostenotic features (rings, strictures) to provide a comprehensive assessment of disease severity.
5-item 500-point scale grading irritable bowel syndrome severity.
Predicts poor prognosis in non-acetaminophen acute liver failure to guide transplant referral.
Determines presence of IBS using clinically significant weighted criteria including symptoms and laboratory parameters to differentiate IBS from organic gastrointestinal disease
Predicts mortality in alcoholic hepatitis patients not responding to steroid therapy
Predicts risk of liver decompensation after hepatectomy for hepatocellular carcinoma (HCC)
Predicts cirrhosis probability in chronic hepatitis C from platelets, AST/ALT ratio and INR.
Stratifies severity of esophagitis based on endoscopic findings, recommended by ACG guidelines
Predicts prognosis and steroid benefit in alcoholic hepatitis
Determines likelihood of irritable bowel syndrome diagnosis based on six clinically significant criteria related to abdominal pain and stool characteristics. Developed in 1978 from study of 109 patients with abdominal symptoms. Requires at least 3 of 6 criteria to suggest IBS diagnosis.
Assesses severity of ulcerative colitis using four clinical and endoscopic parameters. Originally developed in 1987 to standardize assessment of ulcerative colitis activity and treatment response in clinical trials and practice. Widely used instrument for evaluating disease severity and monitoring therapeutic outcomes.
Offers multiple versions of MELD for liver transplant planning and end-stage liver disease severity assessment
Quantifies end-stage liver disease for transplant planning with sodium, used by UNOS for liver allocation since 2016
Quantifies end-stage liver disease for transplant planning using the original pre-2016 formula without sodium
Assesses suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma (HCC), recommended by AASLD guidelines
Modified CT Severity Index for acute pancreatitis (Mortele 2004): pancreatic inflammation (0/2/4), pancreatic necrosis (0/2/4), extrapancreatic complications (0/2); total 0-10. 0-2 mild, 4-6 moderate, 8-10 severe.
Modified Hinchey classification (Wasvary/Kaiser) for acute diverticulitis severity: 0 mild clinical; Ia confined pericolic inflammation/phlegmon; Ib pericolic/mesocolic abscess; II pelvic or distant abscess; III generalized purulent peritonitis; IV fecal peritonitis. Implemented from the published classification (AGPL source repo not copied).
Classifies phenotype and severity of Crohn's disease and ulcerative colitis to guide treatment decisions and predict disease course.
Montreal classification of Crohn's disease (2005): Age at diagnosis (A1 ≤16, A2 17-40, A3 >40), Location (L1 ileal, L2 colonic, L3 ileocolonic, L4 isolated upper GI modifier), Behavior (B1 non-stricturing/non-penetrating, B2 stricturing, B3 penetrating, p perianal modifier).
Montreal classification of ulcerative colitis (2005): Extent (E1 ulcerative proctitis, E2 left-sided/distal, E3 extensive/pancolitis) and Severity (S0 remission, S1 mild, S2 moderate, S3 severe).
Predicts 30-day readmission risk in patients with cirrhosis following hospital discharge. This prognostic tool helps clinicians identify high-risk patients who may benefit from enhanced discharge planning, close outpatient follow-up, and preventive interventions to reduce readmission rates.
Diagnoses steatohepatitis based on histological findings in NAFLD patients. The NAS evaluates disease activity by scoring three histological features: steatosis, lobular inflammation, and hepatocellular ballooning.
Estimates amount of scarring in the liver based on various lab tests. Distinguishes between patients with nonalcoholic fatty liver disease who have (F3-F4) and do not have (F0-F2) advanced fibrosis.
The partial Mayo score grades ulcerative colitis activity without endoscopy: stool frequency, rectal bleeding, physician global assessment, each 0-3. Total 0-9.
11 criteria (5 at admission, 6 at 48h) predicting mortality in acute pancreatitis.
Predict severity/mortality of acute pancreatitis (11 criteria).
Classifies acute pancreatitis: mild, moderately severe, or severe (persistent organ failure).
Full Rockall score for upper GI bleeding: mortality and rebleeding risk.
Official Rome IV diagnostic criteria for proctalgia fugax, a functional anorectal pain disorder characterized by sudden, severe, episodic rectal pain unrelated to defecation. This validated diagnostic tool helps differentiate proctalgia fugax from other anorectal pain syndromes including levator ani syndrome and unspecified functional anorectal pain.
Official Rome IV diagnostic criteria for reflux hypersensitivity, a functional esophageal disorder characterized by retrosternal symptoms triggered by normal amounts of gastroesophageal reflux. This validated diagnostic tool distinguishes reflux hypersensitivity from GERD and functional heartburn through specific investigations including pH monitoring with normal acid exposure but positive symptom-reflux association.
Official Rome IV diagnostic criteria for rumination syndrome in adults, a functional gastroduodenal disorder characterized by effortless regurgitation of recently ingested food followed by remastication and reswallowing or expulsion. This validated diagnostic tool distinguishes rumination syndrome from GERD and other gastroesophageal disorders through specific clinical criteria emphasizing effortless regurgitation without retching or nausea.
Official Rome IV diagnostic criteria for unspecified functional bowel disorder, a catch-all diagnosis for functional bowel symptoms that do not meet specific criteria for IBS, functional constipation, functional diarrhea, or functional abdominal bloating/distension. This diagnosis applies to patients with bowel symptoms not attributable to organic etiology that persist for ≥3 months with onset ≥6 months prior to diagnosis.
9-item laryngopharyngeal reflux symptom scale, each 0-5; > 13 considered abnormal.
Endoscopic recurrence grading after ileocolonic resection: i0-i4.
SAAG = serum albumin - ascitic albumin; >= 1.1 g/dL indicates portal hypertension.
Ulcerative colitis activity: 0-19; >= 5 indicates active disease.
Endoscopic Crohn's severity: 4 variables x 5 segments (0-3 each); 0-2 remission, 3-6 mild, 7-15 moderate, >=16 severe.
Tokyo Guidelines 2018 (TG18) severity grading for acute cholangitis. Grade III (severe): any organ dysfunction. Grade II (moderate): no organ dysfunction but ≥2 of: WBC >12,000/<4,000, fever ≥39°C, age ≥75, bilirubin ≥5 mg/dL, albumin <0.7×LLN. Grade I (mild): neither.
Provides diagnostic criteria and severity grading for acute cholecystitis according to TG18 (Tokyo Guidelines 2018).
Predicts risk of needing colectomy with severe ulcerative colitis. Used on day 3 of treatment for acute severe ulcerative colitis to predict failure of medical therapy.
Stratifies severity of ulcerative colitis into mild, moderate, or severe categories based on clinical and laboratory parameters
Ulcerative Colitis Endoscopic Index of Severity (UCEIS, Travis 2012): three descriptors scored at the worst-affected segment — vascular pattern (1-3), bleeding (1-4), erosions/ulcers (1-4). Total 3-11; higher scores indicate more severe endoscopic disease.
Predicts mortality in end-stage liver disease patients for liver transplant planning. Developed specifically for UK population to determine eligibility for liver transplantation and estimate patient prognosis.
Wexner (Cleveland Clinic Florida) Fecal Incontinence Score: 5 items (solid, liquid, gas incontinence; pad use; lifestyle alteration), each rated 0 (never) to 4 (always). Total 0-20; 0 = perfect continence, 20 = complete incontinence.
Stratifies severity of fecal incontinence in patients with obstructed defecation syndrome. Also known as the Cleveland Clinic Fecal Incontinence Score (CCFIS), this validated scoring system evaluates five key aspects of fecal incontinence to provide objective assessment of symptom severity and impact on quality of life.
Clinical Decision Support (CDS) Notice & Legal Disclaimer
All calculations and clinical scoring tools in this directory are intended strictly for educational and decision-support use by licensed medical practitioners. They do not constitute autonomous medical advice or direct treatment orders. See the full DexaMed Medical Disclaimer.